文献速递外周动脉疾病

开放与腔内血运重建治疗严重肢体缺血后一年再入院分析

One-Year Readmission after Open and Endovascular Revascularization for Critical Limb Ischemia.
PubMed 文献 · Ann Vasc Surg · 2019-07-31

基于2014年美国全国再入院数据库,纳入1月接受下肢血运重建的严重肢体缺血患者,比较开放与腔内手术。腔内组患者更年长、合并症更多,再入院率(49% vs 33.7%)和死亡率(10.4% vs 5.3%)更高;开放手术独立降低再入院风险(OR=0.55),但两组再次血运重建和截肢无差异。

要点

  • 腔内血运重建患者更年长、女性比例更高、Charlson合并症指数更高。
  • 腔内组一年再入院率和死亡率显著高于开放组,开放手术独立降低再入院风险。
  • 两组再次血运重建和重大截肢率无显著差异,再入院患者常需至少一次血运重建。

核心结论

  • 严重肢体缺血腔内血运重建患者更年长且合并症更多,一年再入院风险高于开放手术。
  • 开放手术独立降低再入院风险,但两组重大截肢和再次血运重建无差异。

研究设计与样本

  • 回顾性队列研究,使用2014年美国全国再入院数据库,纳入1月接受下肢血运重建的患者。
  • 共1668例开放手术和1410例腔内手术,比较一年再入院、再次血运重建、截肢和住院死亡。

主要发现

  • 腔内组再入院率49% vs 开放组33.7%(P<0.01),死亡率10.4% vs 5.3%(P<0.01)。
  • 腔内组再入院患者平均再入院次数2.49±0.12 vs 开放组2.13±0.08(P=0.01)。

关键数值与推荐

  • 腔内组年龄更大、女性更多、Charlson合并症指数更高(均P<0.01)。

临床怎么用

  • 严重肢体缺血选择腔内血运重建时应评估再入院风险,尤其对高龄、合并症多者。
  • 开放手术可能降低一年再入院风险,但需结合患者个体情况权衡。

局限性

  • 回顾性数据库研究,仅纳入1月手术患者以追踪一年再入院,可能存在选择偏倚。
  • 未报告具体混杂因素控制细节及未测量混杂的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lower extremity revascularization for critical limb ischemia (CLI) remains a subject of clinical equipoise. Readmissions and repeat lower extremity revascularization increase the cost of care and decrease the value of initial treatment. This study examines readmissions and repeat inpatient revascularization and major amputation up to 1 year after initial open and endovascular lower extremity revascularization. METHODS: The 2014 Nationwide Readmissions Database (NRD) was reviewed. The NRD provides all subsequent readmissions of any hospitalization for the calendar year. A cohort of patients undergoing lower extremity revascularization in January only was selected based on International Classification of Diseases, Ninth Revision, Clinical Modification codes. Patients were divided into open and endovascular groups. Readmissions for repeat lower extremity revascularization (RFR) were identified based on procedural codes. Open and endovascular lower extremity revascularization were compared in terms of patient characteristics as well as readmissions, RFR, major amputation, and inpatient mortality at 1 year. Risk-adjusted outcomes accounting for differences in age, gender, income, and Charlson Comorbidity Index (CCI) were derived using regression analysis. RESULTS: There were 1,668 open and 1,410 endovascular lower extremity revascularizations. Patients in the endovascular group were significantly older (P < 0.01), more likely to be women (P < 0.01), and had higher CCI (P < 0.01). Patients undergoing endovascular lower extremity revascularization had significantly higher readmission rate (49 vs. 33.7, P < 0.01) and higher mortality (10.4 vs. 5.3, P < 0.01). Readmitted patients after endovascular lower extremity revascularization had significantly higher mean number of repeat readmissions compared to open lower extremity revascularization (2.49 ± 0.12 vs. 2.13 ± 0.08, P = 0.01). There was no difference in RFR (P = 0.82) or major amputation (P = 0.19). Open revascularization was independently associated with decreased readmission (odds ratio = 0.55 [0.43-0.71]) compared to endovascular. However, there was no significant association between the type of lower extremity revascularization and major amputation or RFR. CONCLUSIONS: Endovascular lower extremity revascularization for CLI is performed on older and sicker patients and seems to be associated with increased readmission at 1 year compared to open lower extremity revascularization. Regardless of the initial modality of treatment, patients are likely to undergo at least 1 revascularization during readmissions.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ochoa Chaar CI, Gholitabar N, Goodney P, et al. One-Year Readmission after Open and Endovascular Revascularization for Critical Limb Ischemia. Ann Vasc Surg. 2019. PMID: 31376536. doi:10.1016/j.avsg.2019.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。